Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects 04/01/2019 INTERVENTIONAL unchanged 2,704.85 0 PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate 04/03/2019 INTERVENTIONAL unchanged 2,702.85 0 Preimplantation Genetic Testing for Aneuploidies in Patients With Recurrent Implantation Failure 04/03/2019 INTERVENTIONAL unchanged 2,702.85 0 Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer 04/03/2019 INTERVENTIONAL unchanged 2,702.85 0 Effect of Prednisolone Treatment on Uterine Natural Killer Cells 04/04/2019 INTERVENTIONAL unchanged 2,701.85 0 Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer 04/09/2019 INTERVENTIONAL unchanged 2,696.85 0 Oxytocin Receptor Expression in Pregnancy 04/09/2019 OBSERVATIONAL unchanged 2,696.85 0 Fit-for-Fertility Multicenter Randomized Controlled Trial 04/09/2019 INTERVENTIONAL unchanged 2,696.85 0 Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma 04/10/2019 INTERVENTIONAL unchanged 2,695.85 0 DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome 04/11/2019 OBSERVATIONAL unchanged 2,694.85 0 Study of Treatment for HPV16+ ASC-US or LSIL 04/12/2019 INTERVENTIONAL unchanged 2,693.85 0 Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer 04/16/2019 INTERVENTIONAL unchanged 2,689.85 0 The Pregnancy & Early Life Study 04/16/2019 OBSERVATIONAL unchanged 2,689.85 0 Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women 04/16/2019 INTERVENTIONAL unchanged 2,689.85 0 Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer 04/16/2019 INTERVENTIONAL unchanged 2,689.85 0 Single Pre-Operative Radiation Therapy - With Delayed Surgery for Low Risk Breast Cancer 04/17/2019 INTERVENTIONAL unchanged 2,688.85 0 Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes 04/22/2019 OBSERVATIONAL unchanged 2,683.85 0 Transcriptome Profiling and Endometrial Receptivity 04/24/2019 OBSERVATIONAL unchanged 2,681.85 0 Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection 04/25/2019 INTERVENTIONAL unchanged 2,680.85 0 Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP) 04/25/2019 OBSERVATIONAL unchanged 2,680.85 0 Consequences of Unwanted Pregnancy in Nepal 04/29/2019 OBSERVATIONAL unchanged 2,676.85 0 Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer 04/30/2019 INTERVENTIONAL unchanged 2,675.85 0 An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD) 05/03/2019 OBSERVATIONAL unchanged 2,672.85 0 Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer 05/03/2019 INTERVENTIONAL unchanged 2,672.85 0 Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders 05/06/2019 INTERVENTIONAL unchanged 2,669.85 0 Women's Advanced Risk-assessment in Manitoba 05/06/2019 OBSERVATIONAL unchanged 2,669.85 0 Usability Study of the Sensors and eMOM GDM Application 05/08/2019 OBSERVATIONAL unchanged 2,667.85 0 Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer 05/08/2019 INTERVENTIONAL unchanged 2,667.85 0 Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery 05/09/2019 INTERVENTIONAL unchanged 2,666.85 0 Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies 05/09/2019 OBSERVATIONAL unchanged 2,666.85 0 Phase III Study of MR-Guided Focused Ultrasound Surgery for the Treatment of Uterine Fibroids Compared to Myomectomy 05/14/2019 INTERVENTIONAL unchanged 2,661.85 0 Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer 05/14/2019 INTERVENTIONAL unchanged 2,661.85 0 The CoPenHagen PREeClampsia and cardIOvascUlar diSease Study 05/14/2019 OBSERVATIONAL unchanged 2,661.85 0 Autologous Platelet Rich Plasma (PRP) Intra Ovarian Infusion in Perimenopausal Women 05/15/2019 INTERVENTIONAL unchanged 2,660.85 0 Platino-resistance in Ovarian Cancer 05/17/2019 INTERVENTIONAL unchanged 2,658.85 0 High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT) 05/17/2019 INTERVENTIONAL unchanged 2,658.85 0 Clinical Trial of Minimally Invasive Surgery Versus Abdominal Surgery in Patients With Early Stage Cervical Cancer 05/20/2019 INTERVENTIONAL unchanged 2,655.85 0 TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer 05/20/2019 INTERVENTIONAL unchanged 2,655.85 0 Physiotherapy Treatment for Gynecological Cancer Survivors With Urinary Incontinence 05/21/2019 INTERVENTIONAL unchanged 2,654.85 0 Clinico-biological Data Collection Study of Metastatic Breast Cancer 05/21/2019 INTERVENTIONAL unchanged 2,654.85 0 AKT Inhibitor, Ipatasertib, With Endocrine and CDK 4/6 Inhibitor for Patients With Metastatic Breast Cancer (TAKTIC) 05/22/2019 INTERVENTIONAL unchanged 2,653.85 0 Cancer Activity and Lifestyle Measurement Study 05/23/2019 OBSERVATIONAL unchanged 2,652.85 0 Quality of Life, Aesthetic Result and Health Economy in Breast Reconstruction 05/24/2019 INTERVENTIONAL unchanged 2,651.85 0 PET/MR Versus CECT Scans in Imaging Patients With Ovarian Cancer or Highly Suspected Ovarian Cancer 05/29/2019 INTERVENTIONAL unchanged 2,646.85 0 A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer 05/31/2019 OBSERVATIONAL unchanged 2,644.85 0 EASE: The Materna Prep Pivotal Study 06/04/2019 INTERVENTIONAL unchanged 2,640.85 0 Tocolysis in the Management of Preterm Premature Rupture of Membranes Before 34 Weeks of Gestation 06/05/2019 INTERVENTIONAL unchanged 2,639.85 0 Three Fraction Radiation to Induce Immuno-Oncologic Response 06/07/2019 INTERVENTIONAL unchanged 2,637.85 0 A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer 06/10/2019 INTERVENTIONAL unchanged 2,634.85 0 Fetal Endotracheal Occlusion (FETO) in the Resolution of Pulmonary Hypertension in Fetuses With Severe CDH 06/10/2019 INTERVENTIONAL unchanged 2,634.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology